Key Takeaways: Most people experience mild nausea, low energy, or a shift in appetite in the first week
Digestion, Gut Health, Microbiome
Patients living with obesity will often have been made to feel responsible for their condition, and could have significant feelings of shame and guilt if they do not have any, or less than average, weight loss
Diabetes 68(5):906917 Gentilella R, Pechtner V, Corcos A, Consoli A (2019) Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same
The evidence supporting reduced side effects comes from three sources: pharmacokinetic modeling, anecdotal reports, and inference from studies on GI tolerability during dose escalation